Biotech Stock News (LXRX) (BIOC) (LLY) (AMGN) (AQXP)

Lexicon Pharmaceuticals (NASDAQ:LXRX)  On August 3, 2015 shares of Lexicon Pharmaceuticals were up 61% after the company posted positive phase 3 Results in Patients with Carcinoid Syndrome. Carcinoid Syndrome occurs when a carcinoid tumor advances to a later stage. Typically this disease targets the lining of the lungs or stomach of the patient and has … Read more